
Reya M Sharman, MD
Main:
(520) 694-2873
Fax: (520) 742-4110
Fax: (520) 742-4110
1891 West Orange Grove Road, Building 1, Tucson, Arizona, 85704
About us
In addition to being a cancer physician, I am also purveyor of health and wellness. I believe that there are systems of medicine outside of our biomedical model that are crucial to providing wholesome healthcare to people. In my practice, my favorite part of the conversation is discussing the health of the mind, body, and soul. I incorporate integrative modalities (such as meditation, exercise, supplements, and nutrition in cancer) to some degree in the care of all my patients.
Find Support at Banner Health.
Languages | English |
Tags | iron infusion therapy, blood transfusion therapy, bone marrow aspiration, relapsed non hodgkin lymphoma, relapsed hodgkin lymphoma, lymphoproliferative disorder, alk negative anaplastic large cell lymphoma, smoldering multiple myeloma, extranodal nk t cell lymphoma, primary effusion lymphoma, primary splenic lymphoma, nodular lymphocyte predominant hodgkin lymphoma, disseminated intravascular coagulation, hiv lymphoma, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, chimeric antigen receptor t cell therapy, mucosa associated lymphoid tissue lymphoma, mediastinal lymphoma, gray zone lymphoma, peripheral t cell lymphoma, small lymphocytic lymphoma, leukocytosis, anemia and bone marrow disorders, white blood cell disorders, red blood cell disorders, plasma cell and antibody production disorders, iron metabolism disorders, cold agglutinin disease, coagulation disorders, bone marrow failure syndromes, autoimmune hemolytic anemia, hodgkin lymphoma, marginal zone lymphoma, mantle zone lymphoma, large granular lymphocytic leukemia, hematologic malignancies, bone marrow biopsy, anaplastic large cell lymphoma, adult t cell lymphoma, thrombotic thrombocytopenic purpura, sezary syndrome, multiple myeloma, deep vein thrombosis, deep thrombophlebitis, cutaneous lymphoma, cutaneous b cell lymphoma, cns lymphoma, chronic lymphocytic leukemia, catastrophic antiphospholipid syndrome (caps), burkitt lymphoma, platelet disorder, blood clotting disorder, blood clot, antiphospholipid syndrome, anticoagulation, de-escalation treatment, neoadjuvant treatment, neurotrophic tyrosine receptor kinase gene fusion, complement mediated hemolytic uremic syndrome, chemotherapy toxicity, decreased hemoglobin, iron replacement, iron level, iron binding capacity, ferritin, cardiolipin antibody assay, hydroxyurea therapy, hypersplenism, acquired factor inhibitor, plasmacytoma, monoclonal paraproteinemia, adjuvant chemotherapy, prolonged partial thromboplastin time, prolonged prothrombin time, plasmablastic lymphoma, neutrophilia, monoclonal b-cell lymphocytosis, macrocytosis, follicular t-cell lymphoma, elevated hemoglobin, b cell lymphoproliferative disorder, elevated transferrin saturation, elevated ferritin, high iron, autoimmune (aa) amyloidosis, light chain (al) amyloidosis, solitary plasmacytoma, metastatic blood cancers, human t-cell lymphotropic virus type 1, human t-cell lymphotropic virus type 2, thrombotic microangiopathy, paraprotein associated cryoglobulinemia, monoclonal gammopathy of renal significance, abnormal protein, blood cancer chemotherapy, clinical trials, waldenstrom macroglobulinemia |
Video | https://www.youtube.com/watch?v=tyKDOII1320 |